These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

52 related items for PubMed ID: 2772309

  • 1. [Biochemical plasma changes in essential hypertension patients treated for a year].
    Baños Gallardo M, Argüelles Toraño M, Rojo Ortega JM.
    Rev Clin Esp; 1989 Apr; 184(7):347-51. PubMed ID: 2772309
    [Abstract] [Full Text] [Related]

  • 2. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M, Richter WO, Schwandt P, Holzgreve H.
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [Abstract] [Full Text] [Related]

  • 3. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A.
    Blood Press Suppl; 1995 Jun; 3():38-46. PubMed ID: 8535541
    [Abstract] [Full Text] [Related]

  • 4. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
    Lindholm LH, Persson M, Alaupovic P, Carlberg B, Svensson A, Samuelsson O.
    J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
    [Abstract] [Full Text] [Related]

  • 5. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL, Finomo FO, Kadiri S, Arije A, Olatosin AO.
    Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
    [Abstract] [Full Text] [Related]

  • 6. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 7. [Biochemical changes in hypertensive patients during a 1-year cross-over study of treatment with hydrochlorothiazide and propranolol].
    Bagatin J, Rumboldt Z, Polić S, Sardelić S, Ljutić D, Capkun V, Pivac N, Petrović P, Bojić L.
    Lijec Vjesn; 1996 Mar; 118(1-2):11-6. PubMed ID: 8759414
    [Abstract] [Full Text] [Related]

  • 8. Comparative effects of atenolol versus nifedipine on serum lipids and other biochemical parameters in diabetic and non-diabetic hypertensive subjects.
    Satia MC, Shukla ML, Goyal RK.
    Indian J Physiol Pharmacol; 1995 Jul; 39(3):237-41. PubMed ID: 8550116
    [Abstract] [Full Text] [Related]

  • 9. Long-term effects of diltiazem and atenolol on blood glucose, serum lipids, and serum urate in hypertensive patients. Swedish-Finnish Study Group.
    Thulin T, Lehtonen A, Dahlöf C, Nilsson-Ehle P, Engqvist L, Lagerstedt C, Berglund E.
    Int J Clin Pharmacol Ther; 1999 Jan; 37(1):28-33. PubMed ID: 10027480
    [Abstract] [Full Text] [Related]

  • 10. Prazosin improves atherogenic index and inhibits the deleterious effect of dihydrochlorothiazide in patients with essential hypertension.
    Farsang C, Péter M, Balás-Eltes A, Fehér J.
    J Cardiovasc Pharmacol; 1987 Jan; 10 Suppl 12():S240-3. PubMed ID: 2455187
    [Abstract] [Full Text] [Related]

  • 11. [Serum levels of uric acid, lipids and glucose in essential hypertension].
    Bogdanovska S, Zafirovska K, Lozance Lj, Masin-Paneva J.
    Srp Arh Celok Lek; 1996 Jan; 124 Suppl 1():214-6. PubMed ID: 9102912
    [Abstract] [Full Text] [Related]

  • 12. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T, Lehtonen A.
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [Abstract] [Full Text] [Related]

  • 13. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 14. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
    Joglekar SJ, Jaguste V, Nanivadekar AS.
    J Assoc Physicians India; 1998 Sep; Suppl 1():41-51. PubMed ID: 11233386
    [Abstract] [Full Text] [Related]

  • 15. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H, Schmidt J, Derendorf H.
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [Abstract] [Full Text] [Related]

  • 16. [Metabolic changes in the patient with essential hypertension].
    Nami R, Martinelli M, Simone G, Panza F, Saia F, Gennari C.
    Minerva Cardioangiol; 1992 Mar; 40(3):57-64. PubMed ID: 1630676
    [Abstract] [Full Text] [Related]

  • 17. Changes in plasma lipids and uric acid with sodium loading and sodium depletion in patients with essential hypertension.
    Masugi F, Ogihara T, Hashizume K, Hasegawa T, Sakaguchi K, Kumahara Y.
    J Hum Hypertens; 1988 Mar; 1(4):293-8. PubMed ID: 3221377
    [Abstract] [Full Text] [Related]

  • 18. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
    Leonetti G, Italian Study Group on Nilvadipine in Mild to Moderate Hypertension.
    Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 20. [Transmembrane Na+ transport kinetics in arterial hypertension: relations with vascular risk parameters].
    Caballero Oliver A, Stiefel García-Junco P, García-Donas López MA, Villar Ortiz J, Carneado de la Fuente J.
    Med Clin (Barc); 1995 Dec 08; 105(20):768-73. PubMed ID: 8558976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.